Ivermectin is also used + see Dr Judy Mikovits
Suramin is a 100 yr old drug developed for African sleeping sickness & river blindness. It was investigated for other diseases & cancer but was not approved for any therapeutic use in the US.
A small, randomized clinical trial conducted by Robert Naviaux, MD, PhD, professor of medicine, pediatrics & pathology & colleagues at U of CA- San Diego School of Medicine found that a single intravenous dose of Suramin produced dramatic, but transient, improvement of core symptoms of autism spectrum disorder, ASD. Currently, there are no drugs approved for treating the core symptoms of ASD.
More broadly, the trial findings support the “cell danger response theory,” which posits that autism & other chronic conditions are fundamentally driven by metabolic dysfunction & thus treatable. Naviaux & his co-authors propose larger, longer clinical trials to assess Suramin or similar drugs as ASD treatments